Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2021

Dec 30, 2021

29745_dirs_2021-12-30_09511f7e-bebf-4f96-af6d-28ddcd1227e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-12-28

Reporting Person: Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-28 Restricted Stock Unit $ A 3618 Acquired Common Stock (3618.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vest on February 1, 2024.